{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:55:53Z","timestamp":1757454953476},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00393-024-01523-w","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T06:01:40Z","timestamp":1718172100000},"page":"471-484","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Idiopathische inflammatorische Myopathien","Idiopathic inflammatory myopathies"],"prefix":"10.1007","volume":"83","author":[{"given":"Dana","family":"Lemmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Ruck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Sch\u00e4nzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Triantafyllias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Hasseli-Fr\u00e4bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"1523_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg\u00a0IE, Fujimoto\u00a0M, Vencovsky\u00a0J et\u00a0al (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 7:86. https:\/\/doi.org\/10.1038\/s41572-021-00321-x","journal-title":"Nat Rev Dis Primers"},{"key":"1523_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","volume":"19","author":"DB Johnson","year":"2022","unstructured":"Johnson\u00a0DB, Nebhan\u00a0CA, Moslehi\u00a0JJ et\u00a0al (2022) Immune-checkpoint inhibitors: long-term implications of toxicity. Nat Rev Clin Oncol 19:254\u2013267. https:\/\/doi.org\/10.1038\/s41571-022-00600-w","journal-title":"Nat Rev Clin Oncol"},{"key":"1523_CR3","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1158\/2159-8290.CD-22-1180","volume":"13","author":"J-E Salem","year":"2023","unstructured":"Salem\u00a0J\u2011E, Bretagne\u00a0M, Abbar\u00a0B et\u00a0al (2023) Abatacept\/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discov 13:1100\u20131115. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-1180","journal-title":"Cancer Discov"},{"key":"1523_CR4","doi-asserted-by":"publisher","first-page":"e200177","DOI":"10.1212\/NXI.0000000000200177","volume":"11","author":"C Nelke","year":"2024","unstructured":"Nelke\u00a0C, Pawlitzki\u00a0M, Kerkhoff\u00a0R et\u00a0al (2024) Immune Checkpoint Inhibition-Related Myasthenia-Myositis-Myocarditis Responsive to Complement Blockade. Neurol Neuroimmunol Neuroinflammation 11:e200177. https:\/\/doi.org\/10.1212\/NXI.0000000000200177","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1523_CR5","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg\u00a0IE, Tj\u00e4rnlund\u00a0A, Bottai\u00a0M et\u00a0al (2017) EULAR\/ACR Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and their Major Subgroups. Ann Rheum Dis 76:1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"1523_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-023-01454-y","author":"I Georgi","year":"2023","unstructured":"Georgi\u00a0I, Georgi\u00a0M, Haas\u00a0J\u2011P (2023) Fortschritte in der Diagnostik und Therapie der juvenilen Dermatomyositis. Z\u00a0Rheumatol. https:\/\/doi.org\/10.1007\/s00393-023-01454-y","journal-title":"Z Rheumatol"},{"unstructured":"Wiendl H, Schmidt J et al (2022) Myositissyndrome, S2k-Leitlinie, in: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg.), Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. Online: https:\/\/www.dgn.org\/leitlinien (abgerufen am 02.06.2024)","key":"1523_CR7"},{"key":"1523_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","volume":"16","author":"Y Allenbach","year":"2020","unstructured":"Allenbach\u00a0Y, Benveniste\u00a0O, Stenzel\u00a0W et\u00a0al (2020) Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol 16:689\u2013701. https:\/\/doi.org\/10.1038\/s41584-020-00515-9","journal-title":"Nat Rev Rheumatol"},{"unstructured":"Aids to the Examination of the Peripheral Nervous System. Memorandum No. 45 (superseding War Memorandum No. 7); Council MR. https:\/\/www.ukri.org\/wp-content\/uploads\/2021\/12\/MRC-011221-AidsToTheExaminationOfThePeripheralNervousSystem.pdf 1976","key":"1523_CR9"},{"key":"1523_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20532","author":"LG Rider","year":"2011","unstructured":"Rider\u00a0LG, Werth\u00a0VP, Huber\u00a0AM et\u00a0al (2011) Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index\u20112 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res. https:\/\/doi.org\/10.1002\/acr.20532","journal-title":"Arthritis Care Res"},{"key":"1523_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","volume":"54","author":"P Gerami","year":"2006","unstructured":"Gerami\u00a0P, Schope\u00a0JM, McDonald\u00a0L et\u00a0al (2006) A\u00a0systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis): a\u00a0missing link within the spectrum of the idiopathic inflammatory myopathies. J\u00a0Am Acad Dermatol 54:597\u2013613. https:\/\/doi.org\/10.1016\/j.jaad.2005.10.041","journal-title":"J Am Acad Dermatol"},{"key":"1523_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","volume":"146","author":"MJ Reeder","year":"2010","unstructured":"Reeder\u00a0MJ, Wetter\u00a0DA, Li\u00a0X et\u00a0al (2010) Incidence of Dermatomyositis and Clinically Amyopathic Dermatomyositis: A\u00a0Population-Based Study in Olmsted County, Minnesota. Arch Dermatol 146:26\u201330. https:\/\/doi.org\/10.1001\/archdermatol.2009.328","journal-title":"Arch Dermatol"},{"key":"1523_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/s0190-9622(89)70074-8","volume":"20","author":"NR Rockerbie","year":"1989","unstructured":"Rockerbie\u00a0NR, Woo\u00a0TY, Callen\u00a0JP et\u00a0al (1989) Cutaneous changes of dermatomyositis precede muscle weakness. J\u00a0Am Acad Dermatol 20:629\u2013632. https:\/\/doi.org\/10.1016\/s0190-9622(89)70074-8","journal-title":"J Am Acad Dermatol"},{"key":"1523_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.4321\/s0212-71992006000600006","volume":"23","author":"MA Ruiz Gin\u00e9s","year":"2006","unstructured":"Ruiz Gin\u00e9s\u00a0MA, Calafell Mas\u00a0MF, Ruiz Gin\u00e9s\u00a0JA et\u00a0al (2006) Macro creatine kinase: illness marker. Practical guide for the management. An Med Interna 23:272\u2013275. https:\/\/doi.org\/10.4321\/s0212-71992006000600006","journal-title":"An Med Interna"},{"key":"1523_CR15","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1007\/s10067-023-06599-4","volume":"42","author":"M Shah","year":"2023","unstructured":"Shah\u00a0M, Shinjo\u00a0SK, Day\u00a0J et\u00a0al (2023) Cardiovascular manifestations in idiopathic inflammatory myopathies. Clin Rheumatol 42:2557\u20132575. https:\/\/doi.org\/10.1007\/s10067-023-06599-4","journal-title":"Clin Rheumatol"},{"unstructured":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis \u2013 Betteridge \u2013 2016 \u2013 Journal of Internal Medicine \u2013 Wiley Online Library. https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/joim.12451. Zugegriffen: 19. Nov. 2023","key":"1523_CR16"},{"doi-asserted-by":"publisher","unstructured":"Garc\u00eda-De La Torre I (2015) Clinical Usefulness of Autoantibodies in Idiopathic Inflammatory Myositis. Front Immunol 5(6):331. https:\/\/doi.org\/10.3389\/fimmu.2015.00331. PMID: 26161084; PMCID: PMC4479798.","key":"1523_CR17","DOI":"10.3389\/fimmu.2015.00331"},{"key":"1523_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/joim.12524","volume":"280","author":"IE Lundberg","year":"2016","unstructured":"Lundberg\u00a0IE, Miller\u00a0FW, Tj\u00e4rnlund\u00a0A et\u00a0al (2016) Diagnosis and classification of Idiopathic Inflammatory Myopathies. J\u00a0Intern Med 280:39\u201351. https:\/\/doi.org\/10.1111\/joim.12524","journal-title":"J Intern Med"},{"key":"1523_CR19","first-page":"429","volume":"35","author":"ME Maldonado","year":"2008","unstructured":"Maldonado\u00a0ME, Perez\u00a0M, Pignac-Kobinger\u00a0J et\u00a0al (2008) Clinical and immunologic manifestations of mixed connective tissue disease in a\u00a0Miami population compared to a\u00a0Midwestern US Caucasian population. J\u00a0Rheumatol 35:429\u2013437","journal-title":"J Rheumatol"},{"key":"1523_CR20","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1177\/0961203320918021","volume":"29","author":"N Bitencourt","year":"2020","unstructured":"Bitencourt\u00a0N, Solow\u00a0EB, Wright\u00a0T et\u00a0al (2020) Inflammatory myositis in systemic lupus erythematosus. Lupus 29:776\u2013781. https:\/\/doi.org\/10.1177\/0961203320918021","journal-title":"Lupus"},{"key":"1523_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.55563\/clinexprheumatol\/dkmz6o","volume":"41","author":"S Barsotti","year":"2023","unstructured":"Barsotti\u00a0S, Aringhieri\u00a0G, Mugellini\u00a0B et\u00a0al (2023) The role of magnetic resonance imaging in the diagnostic work-out of myopathies: differential diagnosis between inflammatory myopathies and muscular dystrophies. Clin Exp Rheumatol 41:301\u2013308. https:\/\/doi.org\/10.55563\/clinexprheumatol\/dkmz6o","journal-title":"Clin Exp Rheumatol"},{"key":"1523_CR22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.semarthrit.2016.11.001","volume":"46","author":"J Day","year":"2017","unstructured":"Day\u00a0J, Patel\u00a0S, Limaye\u00a0V (2017) The role of magnetic resonance imaging techniques in evaluation and management of the idiopathic inflammatory myopathies. Semin Arthritis Rheum 46:642\u2013649. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.11.001","journal-title":"Semin Arthritis Rheum"},{"key":"1523_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/mus.24307","volume":"51","author":"J Van De Vlekkert","year":"2015","unstructured":"Van De Vlekkert\u00a0J, Maas\u00a0M, Hoogendijk\u00a0JE et\u00a0al (2015) Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy. Muscle Nerve 51:253\u2013258. https:\/\/doi.org\/10.1002\/mus.24307","journal-title":"Muscle Nerve"},{"key":"1523_CR24","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/mus.25099","volume":"54","author":"S Barsotti","year":"2016","unstructured":"Barsotti\u00a0S, Zampa\u00a0V, Talarico\u00a0R et\u00a0al (2016) Thigh magnetic resonance imaging for the evaluation of disease activity in patients with idiopathic inflammatory myopathies followed in a\u00a0single center. Muscle Nerve 54:666\u2013672. https:\/\/doi.org\/10.1002\/mus.25099","journal-title":"Muscle Nerve"},{"key":"1523_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","volume":"76","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez\u00a0I, Casal-Dominguez\u00a0M, Carrino\u00a0JA et\u00a0al (2017) Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a\u00a0marker of severity. Ann Rheum Dis 76:681\u2013687. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210198","journal-title":"Ann Rheum Dis"},{"key":"1523_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11926-020-00947-y","volume":"22","author":"J Albayda","year":"2020","unstructured":"Albayda\u00a0J, van Alfen\u00a0N (2020) Diagnostic Value of Muscle Ultrasound for Myopathies and Myositis. Curr Rheumatol Rep 22:82. https:\/\/doi.org\/10.1007\/s11926-020-00947-y","journal-title":"Curr Rheumatol Rep"},{"key":"1523_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12969-017-0199-4","volume":"15","author":"AB Orandi","year":"2017","unstructured":"Orandi\u00a0AB, Baszis\u00a0KW, Dharnidharka\u00a0VR et\u00a0al (2017) Assessment, classification and treatment of calcinosis as a\u00a0complication of juvenile dermatomyositis: a\u00a0survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA). Pediatr Rheumatol Online\u00a0J 15:71. https:\/\/doi.org\/10.1186\/s12969-017-0199-4","journal-title":"Pediatr Rheumatol Online J"},{"key":"1523_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/BOR.0000000000000975","volume":"35","author":"AL Tan","year":"2023","unstructured":"Tan\u00a0AL, Di Matteo\u00a0A, Wakefield\u00a0RJ et\u00a0al (2023) Update on muscle imaging in myositis. Curr Opin Rheumatol 35:395\u2013403. https:\/\/doi.org\/10.1097\/BOR.0000000000000975","journal-title":"Curr Opin Rheumatol"},{"key":"1523_CR29","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3899\/jrheum.111597","volume":"39","author":"T Owada","year":"2012","unstructured":"Owada\u00a0T, Maezawa\u00a0R, Kurasawa\u00a0K et\u00a0al (2012) Detection of inflammatory lesions by f\u201118 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis. J\u00a0Rheumatol 39:1659\u20131665. https:\/\/doi.org\/10.3899\/jrheum.111597","journal-title":"J Rheumatol"},{"key":"1523_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000093866","volume":"55","author":"PJ Blijham","year":"2006","unstructured":"Blijham\u00a0PJ, Hengstman\u00a0GJD, Hama-Amin\u00a0AD et\u00a0al (2006) Needle electromyographic findings in 98\u00a0patients with myositis. Eur Neurol 55:183\u2013188. https:\/\/doi.org\/10.1159\/000093866","journal-title":"Eur Neurol"},{"key":"1523_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/nan.12380","volume":"43","author":"Y Allenbach","year":"2017","unstructured":"Allenbach\u00a0Y, Benveniste\u00a0O, Goebel\u00a0H\u2011H et\u00a0al (2017) Integrated classification of inflammatory myopathies. Neuropathol Appl Neurobiol 43:62\u201381. https:\/\/doi.org\/10.1111\/nan.12380","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1523_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1055\/a-0873-7862","volume":"38","author":"A Sch\u00e4nzer","year":"2019","unstructured":"Sch\u00e4nzer\u00a0A, Goebel\u00a0HH, Stenzel\u00a0W (2019) Morphologische Charakteristika der Muskelbiopsie bei inflammatorischen Myopathien. Nervenheilkunde 38:240\u2013248. https:\/\/doi.org\/10.1055\/a-0873-7862","journal-title":"Nervenheilkunde"},{"key":"1523_CR33","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41379-018-0164-x","volume":"32","author":"C Cai","year":"2019","unstructured":"Cai\u00a0C, Anthony\u00a0DC, Pytel\u00a0P (2019) A\u00a0pattern-based approach to the interpretation of skeletal muscle biopsies. Mod Pathol Off J U S Can Acad Pathol Inc 32:462\u2013483. https:\/\/doi.org\/10.1038\/s41379-018-0164-x","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"1523_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00401-022-02438-z","volume":"144","author":"C Preu\u00dfe","year":"2022","unstructured":"Preu\u00dfe\u00a0C, Paesler\u00a0B, Nelke\u00a0C et\u00a0al (2022) Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis. Acta Neuropathol 144:353\u2013372. https:\/\/doi.org\/10.1007\/s00401-022-02438-z","journal-title":"Acta Neuropathol"},{"key":"1523_CR35","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.nmd.2014.06.436","volume":"24","author":"PM Rodr\u00edguez Cruz","year":"2014","unstructured":"Rodr\u00edguez Cruz\u00a0PM, Luo\u00a0Y\u2011B, Miller\u00a0J et\u00a0al (2014) An analysis of the sensitivity and specificity of MHC\u2011I and MHC-II immunohistochemical staining in muscle biopsies for the diagnosis of inflammatory myopathies. Neuromuscul Disord Nmd 24:1025\u20131035. https:\/\/doi.org\/10.1016\/j.nmd.2014.06.436","journal-title":"Neuromuscul Disord Nmd"},{"key":"1523_CR36","doi-asserted-by":"publisher","first-page":"e13155","DOI":"10.1111\/bpa.13155","volume":"33","author":"J Tanboon","year":"2023","unstructured":"Tanboon\u00a0J, Inoue\u00a0M, Hirakawa\u00a0S et\u00a0al (2023) Muscle pathology of antisynthetase syndrome according to antibody subtypes. Brain Pathol Zur Switz 33:e13155. https:\/\/doi.org\/10.1111\/bpa.13155","journal-title":"Brain Pathol Zur Switz"},{"key":"1523_CR37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","volume":"88","author":"A Uruha","year":"2017","unstructured":"Uruha\u00a0A, Nishikawa\u00a0A, Tsuburaya\u00a0RS et\u00a0al (2017) Sarcoplasmic MxA expression: A\u00a0valuable marker of dermatomyositis. Neurology 88:493\u2013500. https:\/\/doi.org\/10.1212\/WNL.0000000000003568","journal-title":"Neurology"},{"key":"1523_CR38","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/nan.12498","volume":"45","author":"S Soponkanaporn","year":"2019","unstructured":"Soponkanaporn\u00a0S, Deakin\u00a0CT, Schutz\u00a0PW et\u00a0al (2019) Expression of myxovirus-resistance protein A: a\u00a0possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis. Neuropathol Appl Neurobiol 45:410\u2013420. https:\/\/doi.org\/10.1111\/nan.12498","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1523_CR39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1177\/08830738050200071201","volume":"20","author":"R Sakuta","year":"2005","unstructured":"Sakuta\u00a0R, Murakami\u00a0N, Jin\u00a0Y et\u00a0al (2005) Diagnostic significance of membrane attack complex and vitronectin in childhood dermatomyositis. J\u00a0Child Neurol 20:597\u2013602. https:\/\/doi.org\/10.1177\/08830738050200071201","journal-title":"J Child Neurol"},{"key":"1523_CR40","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/brain\/aww122","volume":"139","author":"R Lahoria","year":"2016","unstructured":"Lahoria\u00a0R, Selcen\u00a0D, Engel\u00a0AG (2016) Microvascular alterations and the role of complement in dermatomyositis. Brain 139:1891\u20131903. https:\/\/doi.org\/10.1093\/brain\/aww122","journal-title":"Brain"},{"key":"1523_CR41","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.semarthrit.2020.12.009","volume":"51","author":"L Dani","year":"2021","unstructured":"Dani\u00a0L, Lan Che\u00a0W, Lundberg\u00a0IE et\u00a0al (2021) Overall and site-specific cancer before and after diagnosis of idiopathic inflammatory myopathies: A\u00a0nationwide study 2002\u20132016. Semin Arthritis Rheum 51:331\u2013337. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.12.009","journal-title":"Semin Arthritis Rheum"},{"key":"1523_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/biom12010111","volume":"12","author":"AH Opinc","year":"2022","unstructured":"Opinc\u00a0AH, Makowska\u00a0JS (2022) Update on Malignancy in Myositis\u2014Well-Established Association with Unmet Needs. Biomolecules 12:111. https:\/\/doi.org\/10.3390\/biom12010111","journal-title":"Biomolecules"},{"key":"1523_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/medicina57040347","volume":"57","author":"T Fujisawa","year":"2021","unstructured":"Fujisawa\u00a0T (2021) Management of Myositis-Associated Interstitial Lung Disease. Medicina 57:347. https:\/\/doi.org\/10.3390\/medicina57040347","journal-title":"Medicina"},{"key":"1523_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13075-015-0573-x","volume":"17","author":"Y Muro","year":"2015","unstructured":"Muro\u00a0Y, Hosono\u00a0Y, Sugiura\u00a0K et\u00a0al (2015) Anti-PM\/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma. Arthritis Res Ther 17:57. https:\/\/doi.org\/10.1186\/s13075-015-0573-x","journal-title":"Arthritis Res Ther"},{"key":"1523_CR45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1055\/a-2017-8971","volume":"77","author":"M Kreuter","year":"2023","unstructured":"Kreuter\u00a0M, Behr\u00a0J, Bonella\u00a0F et\u00a0al (2023) S1-Leitlinie Interdisziplin\u00e4re Diagnostik interstitieller Lungenerkrankungen im Erwachsenenalter. Pneumologie 77:269\u2013302. https:\/\/doi.org\/10.1055\/a-2017-8971","journal-title":"Pneumologie"},{"unstructured":"Die ProDerm(Progress in Dermatomyositis)-Studie. springermedizin.de. https:\/\/www.springermedizin.de\/dermatomyositis\/die-proderm-progress-in-dermatomyositis-studie\/25438930;. Zugegriffen: 19. Nov. 2023","key":"1523_CR46"},{"key":"1523_CR47","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/rheumatology\/keac115","volume":"61","author":"AGS Oldroyd","year":"2022","unstructured":"Oldroyd\u00a0AGS, Lilleker\u00a0JB, Amin\u00a0T et\u00a0al (2022) British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy. Rheumatology 61:1760\u20131768. https:\/\/doi.org\/10.1093\/rheumatology\/keac115","journal-title":"Rheumatology"},{"key":"1523_CR48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s40674-021-00186-x","volume":"7","author":"A Selva-O\u2019Callaghan","year":"2021","unstructured":"Selva-O\u2019Callaghan\u00a0A, Romero-Bueno\u00a0F, Trallero-Aragu\u00e1s\u00a0E et\u00a0al (2021) Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease. Curr Treatm Opt Rheumatol 7:319\u2013333. https:\/\/doi.org\/10.1007\/s40674-021-00186-x","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"1523_CR49","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.3390\/jcm9113454","volume":"9","author":"E Treppo","year":"2020","unstructured":"Treppo\u00a0E, Infantino\u00a0M, Benucci\u00a0M et\u00a0al (2020) Efficacy and Safety of High-Dose Immunoglobulin-Based Regimen in Statin-Associated Autoimmune Myopathy: A\u00a0Multi-Center and Multi-Disciplinary Retrospective Study. J\u00a0Clin Med 9:3454. https:\/\/doi.org\/10.3390\/jcm9113454","journal-title":"J Clin Med"},{"key":"1523_CR50","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1055\/a-1983-6796","volume":"77","author":"J Behr","year":"2023","unstructured":"Behr\u00a0J, Bonella\u00a0F, Frye\u00a0BC et\u00a0al (2023) Pharmakotherapie der idiopathischen Lungenfibrose (ein Update) und anderer progredienter pulmonaler Fibrosen: S2k-Leitline der Deutsche Gesellschaft f\u00fcr Pneumologie und Beatmungsmedizin e.\u202fV. Pneumologie 77:94\u2013119. https:\/\/doi.org\/10.1055\/a-1983-6796","journal-title":"Pneumologie"},{"unstructured":"- Renale Krise bei Sklerodermie: Wie erkennen, wie behandeln? FAKTEN Rheumatol. https:\/\/www.medmedia.at\/faktenrheumatologie\/renale-krise-bei-sklerodermie-wie-erkennen-wie-behandeln%e2%80%a9\/. Zugegriffen: 27. Jan. 2024","key":"1523_CR51"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01523-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-024-01523-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01523-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T15:06:09Z","timestamp":1723561569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-024-01523-w"}},"subtitle":["Eine interdisziplin\u00e4re Herausforderung","An interdisciplinary challenge"],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1523"],"URL":"https:\/\/doi.org\/10.1007\/s00393-024-01523-w","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"assertion":[{"value":"30 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>D.\u00a0Lemmer:<\/b> A.\u00a0Finanzielle Interessen: D.\u00a0Lemmer gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte Internistin in Ausbildung zur Rheumatologin am Immanuel Krankenhaus Berlin Buch.<b> T.\u00a0Ruck<\/b>: A.\u00a0Finanzielle Interessen: T.\u00a0Ruck gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Stellvertretender Direktor der Klinik f\u00fcr Neurologie des Uniklinikums D\u00fcsseldorf. <b>A.\u00a0Sch\u00e4nzer<\/b>: A.\u00a0Finanzielle Interessen: DGM e.\u00a0V., Sanofi Genzyme finanzielle Forschungsf\u00f6rderung.\u00a0\u2013 Sanofi Genzyme: Referentenhonorar und Reisekostenerstattung.\u00a0\u2013 Patente, Gesch\u00e4ftsanteile, Aktien o.\u202f\u00c4. an einer im Medizinbereich aktiven Firma: Neuronova 10\/246,091 Treatment of Central Nervous System Disorders.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin f\u00fcr Neuropathologie, Institut f\u00fcr Neuropathologie der JL Universit\u00e4t Gie\u00dfen, Deutschland; Leiterin des Neuromuskul\u00e4ren Labors Institut f\u00fcr Neuropathologie der JL Universit\u00e4t Gie\u00dfen, Deutschland; Leiterin des Muskelzentrum Mittel- und Nordhessen der DGM e.V., Mitglied des wissenschaftlichen Beirats der DGM e.\u00a0V. | Mitglied des Referenzzentrums f\u00fcr Nerven- und Muskelerkrankungen der DGNN. <b>K.\u00a0Triantafyllias<\/b>: A.\u00a0Finanzielle Interessen: K.\u00a0Triantafyllias gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Rheumatologe, RZ Rheumazentrum RL\u2011P, Bad Kreuznach; Leitender Oberarzt, RZ Rheumazentrum RL\u2011P, Bad Kreuznach. <b>R.\u00a0Zeng<\/b>: A.\u00a0Finanzielle Interessen: Finanzielle Forschungsf\u00f6rderung durch die Deutsche Gesellschaft f\u00fcr Muskelkranke e.\u202fV. (DGM) und die Deutsche Forschungsgemeinschaft (DFG).\u00a0\u2013 Reise\u2011, \u00dcbernachtungskosten und bezahlte Teilnehmergeb\u00fchren an Konferenzen durch Octapharma, Biogen und LFB.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte \u00c4rztin in Weiterbildung, Klinik f\u00fcr Neurologie, Universit\u00e4tsmedizin G\u00f6ttingen, wissenschaftliche Mitarbeiterin in der Arbeitsgruppe Muskelimmunbiologie, Universit\u00e4tsmedizin G\u00f6ttingen | Mitgliedschaft und Vorstandsposten im MYOSITIS Netz. e.\u202fV.<b> R.\u00a0Hasseli-Fr\u00e4bel<\/b>: A.\u00a0Finanzielle Interessen: R.\u00a0Hasseli-Fr\u00e4bel gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Stellvertretende Leiterin der Sektion Rheumatologie und Klinische Immunologie, Universit\u00e4tsklinikum M\u00fcnster, Sektion f\u00fcr Rheumatologie und Klinische Immunologie, Medizinische Klinik\u00a0D, Abteilung f\u00fcr Translationale Rheumatologie und Immunologie, Institut f\u00fcr Muskuloskelettale Medizin (IMM), Albert-Schweitzer-Campus\u00a01, Geb\u00e4ude A1, 48149 M\u00fcnster | Mitgliedschaften seit 2023: Mitglied des Arbeitsgemeinschaft Kompetenznetz Rheuma der DGRh; seit 2023: Mitglied des kooperativen Rheumazentrums M\u00fcnsterland e.\u202fV.; seit 2023: Mitglied der Kommission \u201eFortbildungen\u201c der BDI; seit 2023: Mitglied von EMerging EULAR NETwork (EMEUNET\/EULAR); seit 2023: Mitglied \u201eProgrammkomitee Kongress 2024\u201c der DGRh; seit 2022: Mitglied der Kommission \u201eMedizinische Fachangestellte\u201c der DGRh; seit 2022: Mitglied der Deutschen Gesellschaft f\u00fcr Innere Medizin & Junge DGIM; seit 2022: Mitglied des Berufsverbands Deutsche Internistinnen und Internisten; seit 2021: Stellvertretende Vorsitzende Myositis-Netz e.\u00a0V.; seit 2021: Mitglied der Kommission \u201eHandlungsempfehlungen COVID-19\u201c der DGRh; seit 2020: Mitglied der Arbeitsgruppe Kapillarmikroskopie der DGRh; seit 2020: Mitglied der Adhoc-Kommission COVID-19 der DGRh; seit 2019: Mitglied der Deutschen Gesellschaft f\u00fcr Immunologie; seit 2019: Mitglied der Deutschen Gesellschaft f\u00fcr Ultraschall in der Medizin; seit 2019: Mitglied des Deutschen Myositis-Netz; seit 2016: Mitglied der Deutschen Gesellschaft f\u00fcr Rheumatologie (DGRH).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient:innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}